1Kasantikul, V, Netsky, MG, Glasscock, ME 3rd, Hays, JW. Acoustic neurilemmoma. Clinicoanatomical study of 103 patients. J Neurosurg 1980;52:28–35
2Erickson, LS, Sorenson, GD, McGavran, MH. A review of 140 acoustic neurinomas (neurilemmoma). Laryngoscope 1965;75:601–27
3Martuza, RL, Ojemann, RG. Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment. Neurosurgery 1982;10:1–12
4Baldwin, D, King, TT, Chevretton, E, Morrison, AW. Bilateral cerebellopontine angle tumors in neurofibromatosis type 2. J Neurosurg 1991;74:910–15
5Neff, BA, Welling, DB, Akhmametyeva, E, Chang, LS. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol Neurotol 2006;27:197–208
6Xiao, GH, Gallagher, R, Shetler, J, Skele, K, Altomare, DA, Pestell, RG et al. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol 2005;25:2384–94
7Aarhus, M, Bruland, O, Saetran, HA, Mork, SJ, Lund-Johansen, M, Knappskog, PM. Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas. Neurosurgery 2010;67:998–1019; discussion 1019
8Bartkova, J, Lukas, J, Strauss, M, Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775–8
9Han, EK, Lim, JT, Arber, N, Rubin, MA, Xing, WQ, Weinstein, IB. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998;35:95–101
10Jares, P, Fernandez, PL, Campo, E, Nadal, A, Bosch, F, Aiza, G et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813–17
11Leach, FS, Elledge, SJ, Sherr, CJ, Willson, JK, Markowitz, S, Kinzler, KW et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993;53:1986–9
12Oyama, T, Kashiwabara, K, Yoshimoto, K, Arnold, A, Koerner, F. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res 1998;58:2876–80
13Seto, M, Yamamoto, K, Iida, S, Akao, Y, Utsumi, KR, Kubonishi, I et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992;7:1401–6
14Sonoki, T, Harder, L, Horsman, DE, Karran, L, Taniguchi, I, Willis, TG et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001;98:2837–44
15Donnellan, R, Chetty, R. Cyclin D1 and human neoplasia. Mol Pathol 1998;51:1–7
16Doglioni, C, Chiarelli, C, Macri, E, Dei Tos, AP, Meggiolaro, E, Dalla Palma, P et al. Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol 1998;185:159–66
17Gerdes, J, Schwab, U, Lemke, H, Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13–20
18Hunter, T, Pines, J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994;79:573–82
19Sagol, O, Tuna, B, Coker, A, Karademir, S, Obuz, F, Astarcioglu, H et al. Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival. Pathol Res Pract 2002;198:77–84
20Xiong, Y, Connolly, T, Futcher, B, Beach, D. Human D-type cyclin. Cell 1991;65:691–9
21Lassaletta, L, Del Rio, L, Torres-Martin, M, Rey, JA, Patron, M, Madero, R et al. Cyclin D1 expression and facial function outcome after vestibular schwannoma surgery. Otol Neurotol 2011;32:136–40
22Lassaletta, L, Patron, M, Del Rio, L, Alfonso, C, Maria Roda, J, Rey, JA et al. Cyclin D1 expression and histopathologic features in vestibular schwannomas. Otol Neurotol 2007;28:939–41
23Neff, BA, Oberstien, E, Lorenz, M, Chaudhury, AR, Welling, DB, Chang, LS. Cyclin D(1) and D(3) expression in vestibular schwannomas. Laryngoscope 2006;116:423–6
24Vielh, P, Chevillard, S, Mosseri, V, Donatini, B, Magdelenat, H. Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors. Am J Clin Pathol 1990;94:681–6
25Bartkova, J, Lukas, J, Muller, H, Lutzhoft, D, Strauss, M, Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353–61
26Chen, CS, Lee, CH, Hsieh, CD, Ho, CT, Pan, MH, Huang, CS et al. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res Treat 2011;125:73–87
27Liu, X, Minin, V, Huang, Y, Seligson, DB, Horvath, S. Statistical methods for analyzing tissue microarray data. J Biopharm Stat 2004;14:671–85
28Pan, J, Tang, T, Xu, L, Lu, JJ, Lin, S, Qiu, S et al. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. Head Neck 2013;35:1238–47
29Aguiar, PH, Tatagiba, M, Dankoweit-Timpe, E, Matthies, C, Samii, M, Ostertag, H. Proliferative activity of acoustic neurilemomas without neurofibromatosis determined by monoclonal antibody MIB 1. Acta Neurochir (Wien) 1995;134:35–9
30Lutchman, M, Rouleau, GA. Neurofibromatosis type 2: a new mechanism of tumor suppression. Trends Neurosci 1996;19:373–7
31Manchanda, PK, Jones, GN, Lee, AA, Pringle, DR, Zhang, M, Yu, L et al. Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors. Oncogene 2013;32:3491–9
32McClatchey, AI, Fehon, RG. Merlin and the ERM proteins–regulators of receptor distribution and signaling at the cell cortex. Trends Cell Biol 2009;19:198–206
33LaJeunesse, DR, McCartney, BM, Fehon, RG. Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J Cell Biol 1998;141:1589–99
34Kissil, JL, Johnson, KC, Eckman, MS, Jacks, T. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 2002;277:10394–9
35Okada, T, Lopez-Lago, M, Giancotti, FG. Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 2005;171:361–71
36Bretscher, A, Edwards, K, Fehon, RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002;3:586–99
37Li, Q, Nance, MR, Kulikauskas, R, Nyberg, K, Fehon, R, Karplus, PA et al. Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain. J Mol Biol 2007;365:1446–59
38Pearson, MA, Reczek, D, Bretscher, A, Karplus, PA. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 2000;101:259–70
39Shimizu, T, Seto, A, Maita, N, Hamada, K, Tsukita, S, Hakoshima, T et al. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain. J Biol Chem 2002;277:10332–6
40Shrestha, Y, Schafer, EJ, Boehm, JS, Thomas, SR, He, F, Du, J et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 2012;31:3397–408
41Xiao, GH, Chernoff, J, Testa, JR. NF2: the wizardry of merlin. Genes Chromosomes Cancer 2003;38:389–99
42Wu, H, Chen, Y, Wang, ZY, Li, W, Li, JQ, Zhang, L et al. Involvement of p21 (waf1) in merlin deficient sporadic vestibular schwannomas. Neuroscience 2010;170:149–55
43Diehl, JA, Cheng, M, Roussel, MF, Sherr, CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998;12:3499–511
44Bartkova, J, Zemanova, M, Bartek, J. Abundance and subcellular localisation of cyclin D3 in human tumours. Int J Cancer 1996;65:323–7
45Fuentealba, L, Schworer, C, Schroering, A, Rahmatullah, M, Carey, DJ. Heregulin and forskolin-induced cyclin D3 expression in Schwann cells: role of a CCAAT promoter element and CCAAT enhancer binding protein. Glia 2004;45:238–48
46Spofford, LS, Abel, EV, Boisvert-Adamo, K, Aplin, AE. Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression. J Biol Chem 2006;281:25644–51
47Charabi, S. Acoustic neuroma/vestibular schwannoma in vivo and in vitro growth models. A clinical and experimental study. Acta Otolaryngol Suppl 1997;530:1–27
48Stangerup, SE, Tos, M, Caye-Thomasen, P, Tos, T, Klokker, M, Thomsen, J. Increasing annual incidence of vestibular schwannoma and age at diagnosis. J Laryngol Otol 2004;118:622–7
49Shoker, BS, Jarvis, C, Davies, MP, Iqbal, M, Sibson, DR, Sloane, JP. Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br J Cancer 2001;84:1064–9
